Should clinicians always administer dexamethasone beyond 24 h after chemotherapy to control delayed nausea and vomiting caused by moderately emetogenic regimens? Insight from the re-evaluation of two randomized studies
Crossref DOI link: https://doi.org/10.1007/s00520-015-2871-x
Published Online: 2015-08-06
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Celio, Luigi
Bonizzoni, Erminio
De Braud, Filippo
Agustoni, Francesco
Aapro, Matti
License valid from 2015-08-06